Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer-Reference-Cited by-同舟云学术

Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer

Published:1996-09 Issue:3 Volume:50 Page:1026-1031
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Merouani Aicha,Shpall Elizabeth J.,Jones Roy B.,Archer Philip G.,Schrier Robert W.

Publisher

Elsevier BV

Subject

Nephrology

Reference17 articles.

1. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer;Peters;J Clin Oncol,1988

2. High-dose alkylating agents and autologous bone marrow support (ABMS) for stage II/III breast cancer involving 10 or more axillary lymph nodes (Duke and CALGB 8782);Peters;Proc Am Soc Clin Onc,1992

3. High-dose combination alkalyting agents with autologous bone marrow support: A phase I trial;Peters;J Clin Oncol,1986

4. Novel toxicities associated with high-dose combination alkalyting agents and autologous bone support;Peters,1986

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis;Kidney International Reports;2024-07

2. Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study;Journal of Nephrology;2023-11-29

3. Prediction of the mechanism for the combination of diallyl trisulfide and cisplatin against gastric cancer: a network pharmacology study and pharmacological evaluation;Frontiers in Pharmacology;2023-10-30

4. Acute kidney injury in autologous hematopoietic stem cell transplant for patients with lymphoma – KDIGO classification with creatinine and urinary output criteria: a cohort analysis;Renal Failure;2023-03

5. Renal Considerations in Critically Ill Hematopoietic Stem Cell Transplant Patients;Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation;2023